City
Epaper

Johnson & Johnson to stop selling talc-based baby powder globally in 2023

By Lokmat English Desk | Updated: August 12, 2022 16:29 IST

US pharmaceutical giant Johnson & Johnson on Thursday announced that it will be discontinuing the sales of its controversial ...

Open in App

US pharmaceutical giant Johnson & Johnson on Thursday announced that it will be discontinuing the sales of its controversial talc-based baby powder globally in 2023. 

The announcement to cease the product sales globally comes two years after J&J halted its sales in USA and Canada. In a statement, the company added that it will be moving from talc-based powders to cornstarch-based baby powder. As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby powder portfolio. As a result of this transition, talc-based J&J Baby Powder will be discontinued globally in 2023," read the company's statement. 

For years, J&J talcum powders, especially baby powders have been at the centre of controversy. Over 38,000 lawsuits have been filed by the consumers as well as the survivors, some of whom allege they were hurt by the use of the product. Some of the lawsuits claim the powder contained cancer-causing material like asbestos.

Tags: Johnson & Johnson
Open in App

Related Stories

HealthJohnson & Johnson asked to pay $18.8 million to man who got cancer from baby powder

HealthEli Lilly's drug to lead obesity, diabetes treatment: Report

HealthJohnson and Johnson offers 8.9 billion dollar settlement of talcum cancer claims

BusinessJohnson & Johnson offers USD 8.9 bln to settle 'talc caused cancer' lawsuits

NationalI had major side effects from 2nd Covid booster shot: Elon Musk

Health Realted Stories

HealthNitish Kumar inaugurates 1050-bed facility at PMCH

HealthDelhi: BJP MLAs to speed up Ayushman card registration in all 70 seats

HealthAnother case in Kerala: Vaccinated child battles for life after turning rabies positive

HealthUS scientists to explore potential of antibody against Long Covid

HealthTobacco, marijuana use to spike heart disease deaths by 50pc in next 5 years